ABX464 50 mg

Drug identity checked against registry records

Also recorded as Obefazimod 50 mg

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisNCT03760003ABVXPhase 2Completed2021-04-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.